SEARCH

SEARCH BY CITATION

References

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 4366.
  • 2
    Yeo CJ,Cameron JL,Lillemoe KD,Sitzmann JV,Hruban RH,Goodman SN,Dooley WC,Coleman J,Pitt HA. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221: 72131.
  • 3
    Evans DB,Lee JE,Pisters PW,Charnsangavej C,Ellis LM,Chiao PJ,Lenzi R,Abbruzzese JL. Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. Cancer Treat Res 1997; 90: 10925.
  • 4
    Pino SM,Xiong HQ,McConkey D,Abbruzzese JL. Novel therapies for pancreatic adenocarcinoma. Curr Oncol Rep 2004; 6: 199206.
  • 5
    Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS 1997; 79: 18.
  • 6
    Koch AE,Polverini PJ,Kunkel SL,Harlow LA,DiPietro LA,Elner VM,Elner SG,Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798801.
  • 7
    Strieter RM,Kunkel SL,Elner VM,Martonyi CL,Koch AE,Polverini PJ,Elner SG. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992; 141: 127984.
  • 8
    Trevino JG,Summy JM,Gray MJ,Nilsson MB,Lesslie DP,Baker CH,Gallick GE. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Res 2005; 65: 721422.
  • 9
    Matsuo Y,Sawai H,Funahashi H,Takahashi H,Sakamoto M,Yamamoto M,Okada Y,Hayakawa T,Manabe T. Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas 2004; 28: 34452.
  • 10
    Summy JM,Trevino JG,Lesslie DP,Baker CH,Shakespeare WC,Wang Y,Sundaramoorthi R,Metcalf CA3rd,Keats JA,Sawyer TK,Gallick GE. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol Cancer Ther 2005; 4: 190011.
  • 11
    Addison CL,Daniel TO,Burdick MD,Liu H,Ehlert JE,Xue YY,Buechi L,Walz A,Richmond A,Strieter RM. The CXC chemokine receptor 2. CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 2000; 165: 526977.
  • 12
    Lane BR,Strieter RM,Coffey MJ,Markovitz DM. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-α production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol 2001; 75: 581222.
  • 13
    Loukinova E,Dong G,Enamorado-Ayalya I,Thomas GR,Chen Z,Schreiber H,Van Waes C. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000; 19: 347786.
  • 14
    Luan J,Shattuck-Brandt R,Haghnegahdar H,Owen JD,Strieter R,Burdick M,Nirodi C,Beauchamp D,Johnson KN,Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997; 62: 58897.
  • 15
    Arenberg DA,Keane MP,DiGiovine B,Kunkel SL,Morris SB,Xue YY,Burdick MD,Glass MC,Iannettoni MD,Strieter RM. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998; 102: 46572.
  • 16
    Noh KW,Pungpapong S,Wallace MB,Woodward TA,Raimondo M. Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases? Clin Gastroenterol Hepatol 2006; 4: 7829.
  • 17
    Frick VO,Rubie C,Wagner M,Graeber S,Grimm H,Kopp B,Rau BM,Schilling MK. Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. Pancreatology 2008; 8: 48897.
  • 18
    Keane MP,Belperio JA,Xue YY,Burdick MD,Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 2004; 172: 285360.
  • 19
    Wislez M,Fujimoto N,Izzo JG,Hanna AE,Cody DD,Langley RR,Tang H,Burdick MD,Sato M,Minna JD,Mao L,Wistuba I,Strieter RM,Kurie JM. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006; 66: 4198207.
  • 20
    Wang B,Hendricks DT,Wamunyokoli F,Parker MI. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 2006; 66: 30717.
  • 21
    Mestas J,Burdick MD,Reckamp K,Pantuck A,Figlin RA,Strieter RM. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005; 175: 53517.
  • 22
    Guha S,Eibl G,Kisfalvi K,Fan RS,Burdick M,Reber H,Hines OJ,Strieter R,Rozengurt E. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res 2005; 65: 273845.
  • 23
    Wente MN,Keane MP,Burdick MD,Friess H,Buchler MW,Ceyhan GO,Reber HA,Strieter RM,Hines OJ. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 2006; 241: 2217.
  • 24
    Matsuo Y,Ochi N,Sawai H,Yasuda A,Takahashi H,Funahashi H,Takeyama H,Tong Z,Guha S. CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009; 124: 85361.
  • 25
    Bouvet M,Wang J,Nardin SR,Nassirpour R,Yang M,Baranov E,Jiang P,Moossa AR,Hoffman RM. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 2002; 62: 153440.
  • 26
    Heidemann J,Ogawa H,Dwinell MB,Rafiee P,Maaser C,Gockel HR,Otterson MF,Ota DM,Lugering N,Domschke W,Binion DG. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003; 278: 850815.
  • 27
    Salcedo R,Resau JH,Halverson D,Hudson EA,Dambach M,Powell D,Wasserman K,Oppenheim JJ. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000; 14: 205564.
  • 28
    Brew R,Erikson JS,West DC,Kinsella AR,Slavin J,Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000; 12: 7885.
  • 29
    Li A,Varney ML,Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001; 7: 3298304.
  • 30
    Zhu YM,Webster SJ,Flower D,Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004; 91: 19706.
  • 31
    Xu L,Fidler IJ. Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 2000; 12: 97106.
  • 32
    Eck M,Schmausser B,Scheller K,Brandlein S,Muller-Hermelink HK. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 2003; 134: 50815.
  • 33
    Schadendorf D,Moller A,Algermissen B,Worm M,Sticherling M,Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993; 151: 266775.
  • 34
    Kamohara H,Takahashi M,Ishiko T,Ogawa M,Baba H. Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: impact of CXCL-8 as an autocrine growth factor. Int J Oncol 2007; 31: 62732.
  • 35
    Ikeda O,Egami H,Ishiko T,Ishikawa S,Kamohara H,Hidaka H,Takahashi M,Ogawa M. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release. Int J Oncol 2006; 28: 93946.
  • 36
    Hidaka H,Ishiko T,Furuhashi T,Kamohara H,Suzuki S,Miyazaki M,Ikeda O,Mita S,Setoguchi T,Ogawa M. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 2002; 95: 120614.
  • 37
    Takamori H,Oades ZG,Hoch OC,Burger M,Schraufstatter IU. Autocrine growth effect of IL-8 and GRO-α on a human pancreatic cancer cell line. Capan-1. Pancreas 2000; 21: 526.
  • 38
    Blood CH,Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89118.
  • 39
    Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 46.